The obesity paradox in pulmonary arterial hypertension: the Scottish perspective

Luke Lawson McLean,Katherine Pellino,Melanie Brewis,Andrew Peacock,Martin Johnson,Alistair Colin Church
DOI: https://doi.org/10.1183/23120541.00241-2019
IF: 4.239
2019-10-01
ERJ Open Research
Abstract:Pulmonary arterial hypertension (PAH) is a rare disease characterised by progressive pulmonary vascular remodelling, resulting in right ventricular failure, which is the principal cause of death [1]. Excessive bodyweight is a well-established independent risk factor for the development of cardiovascular disease and mortality [2]. However, data have emerged for a variety of chronic cardiovascular diseases, particularly heart failure, showing lower long-term mortality in obese patients [3]. This has been termed the "obesity paradox" It challenges clinical reasoning and the significant healthcare expenditure directed toward weight loss in the general population.
What problem does this paper attempt to address?